Noah Doyle serves as Executive at RITTER PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Noah Doyle has executed 6 insider transactions totaling $4.1M, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 12, 2020 involved selling 500,000 shares valued at $110.0K.
Noah Doyle currently holds 704,780 shares of RITTER PHARMACEUTICALS INC (RTTR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Noah Doyle has been a net buyer of RTTR stock. They have purchased $4.0M and sold $110.0K worth of shares.
Noah Doyle's most recent insider trade was on Mar 12, 2020, when they sold 500,000 shares at $0.22 per share.
Get notified when new Form 4 filings are submitted
| $0.15 |
| Discretionary |
| Oct 3, 2017 | RTTR | $0 | Purchase | 5,000,000 | $N/A | Discretionary |
| Jun 29, 2015 | RTTR | $0 | Conversion | 1,247,804 | $N/A | Discretionary |
| Jun 29, 2015 | RTTR | $0 | Conversion | 322,753 | $N/A | Discretionary |
| Jun 24, 2015 | RTTR | $4.0M | Purchase | 800,000 | $5.00 | Discretionary |